Advanced Wound Care
Designed for Infection Control

SubPac® integrates wicking and fluid drainage with an absorbent dressing allowing Advanced Fluid Management in one easy-to-use device — the only subdermal wound dressing of its kind.

FDA 510(k) Cleared US Patent No. 10085892 Zero Infections in All Reported Cases Surgeon Developed
0%
Infection rate across all 14 reported cases
84%
SSI reduction — Lehigh Valley pilot study
$10B
Annual US cost burden of SSIs
$28M
Avg. annual hospital savings by eliminating SSIs
Technology & Method of Use

A complete, single-use subdermal system

SubPac® is a 6-inch wound dressing system utilizing PHMB-treated packing strips available in two widths — 1½ inch and 2½ inch — combined with a multi-layered absorbent wound dressing incorporating Algidex Ag® Silver Alginate.

Applied in under one minute at wound closure. Packing strips inserted subdermally and removed at 48 hours.
Creates an aerobic wound environment inhospitable to the anaerobic bacterial species responsible for most surgical site infections.
Enables primary closure of contaminated incisions that surgeons would otherwise leave open — improving patient quality of life and reducing recovery time.
Zero workflow disruption. Simple Day 2 strip removal. Compatible with all standards of care. Disposable, single-use device.
All patient populations: high-risk (diabetes, stoma, obesity, immunocompromised), infected wounds, emergency/trauma, adult and pediatric.
Pull-tested to 40 lbs. by ETC Innovation manufacturing to address FDA packing strip retention requirements.
Active Antimicrobial Components
ComponentActive AgentFunction
Wound Dressing Algidex Ag®
Silver Alginate Broad-spectrum antimicrobial; promotes moist wound healing
Packing Strips PHMB Antiseptic action; biofilm disruption in the wound bed
Clinical Evidence

Zero infections across all reported cases

Across a case series of 14 high-risk surgical patients at three major New York hospital systems — including patients in septic shock, immunocompromised states, and contaminated wound classifications — SubPac® achieved a zero-infection outcome with no unplanned readmissions.

"SubPac® Wound Care is a patented, FDA 510(k)-cleared subdermal incisional dressing indicated for use in adults and pediatrics. The device is designed to actively remove transudate and exudate from deep within the wound bed into an overlying external dressing. Across all reported cases to date, SubPac® has achieved a zero-infection outcome in high-risk surgical populations."

— Clinical Reference Document · NewYork-Presbyterian Brooklyn Methodist Hospital · New York Community Hospital · Mount Sinai Queens
14
Case Series Patients
SubPac® Device — non-published case series. All high-risk colorectal and general surgical procedures. 0% infection, 0 readmissions.
46
Galler et al. Pilot Study
Open colon resection — high SSI risk. 1 superficial infection / 0 deep tissue infections. 84% SSI reduction vs. standard of care.
243
MacFarlane & Ryan Study
Elective colonic resections (NIH, 1977–1983). 0 superficial infections / 0 deep tissue infections — all patients healed without complication.
Resources

Clinical & business reference documents

Download the full clinical reference document and business overview, or watch the SubPac® product demonstration video.

Clinical Reference Document

4-page clinical evidence summary including full case series data (n=14), technology overview, active antimicrobial components, clinical impact analysis, and references. Study institutions: NewYork-Presbyterian, NY Community Hospital, Mount Sinai Queens.

↓  Download Clinical Reference (PDF)

Business Overview Deck

8-page business deck covering SubPac® technology, clinical evidence summary, market opportunity (infection control market projected $77.67B by 2030), financial impact for medical facilities, and competitive positioning.

↓  Download Business Deck (DOCX)

Product Demonstration Video

Watch a full SubPac® product demonstration including application technique, PHMB wicking strip placement, wound dressing components, and clinical overview. Available on YouTube.

▶  Video Link Coming Soon
Intellectual Property & Regulatory

Patented technology with full regulatory clearance

SubPac® is protected by US and international patents, FDA-cleared, and manufactured under ISO standards in the USA by ETC Innovation.

US Patent No. 10085892
Primary US patent covering the subdermal wound dressing system and method of use. Additional US and international patents may apply. Rights held by Life Sciences LLC, a Delaware limited liability company.
FDA 510(k) Clearance
SubPac® is FDA 510(k)-cleared for use in adults and pediatric populations. Indicated for acute lacerations, traumatic wounds, and complex surgical incisions.
International Patent Protection
International patent protection supports global market development and commercial licensing opportunities across key surgical and wound care markets.
Registered Trademark
SubPac® is a registered trademark. The brand and product identity are protected across all commercial markets. Manufactured exclusively by ETC Innovation, USA.